Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

2.

Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.

Sato T, Yokota S, Okubo T, Ishihara K, Ueno H, Muramatsu Y, Fujii N, Tamura Y.

J Vet Med Sci. 2013 May 2;75(4):407-14. Epub 2012 Nov 14.

3.

Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.

Gibson JS, Cobbold RN, Kyaw-Tanner MT, Heisig P, Trott DJ.

Vet Microbiol. 2010 Nov 20;146(1-2):161-6. doi: 10.1016/j.vetmic.2010.04.012. Epub 2010 Apr 21.

PMID:
20471187
4.

Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.

Karczmarczyk M, Martins M, Quinn T, Leonard N, Fanning S.

Appl Environ Microbiol. 2011 Oct;77(20):7113-20. doi: 10.1128/AEM.00600-11. Epub 2011 Aug 19.

5.

Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.

Liu X, Boothe DM, Thungrat K, Aly S.

Vet Microbiol. 2012 Dec 28;161(1-2):159-68. doi: 10.1016/j.vetmic.2012.07.019. Epub 2012 Jul 20.

PMID:
22877517
6.

Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance.

Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L.

Antimicrob Agents Chemother. 2011 Feb;55(2):921-4. doi: 10.1128/AAC.00996-10. Epub 2010 Nov 22.

7.

Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.

Gebru E, Choi MJ, Lee SJ, Damte D, Park SC.

J Med Microbiol. 2011 Oct;60(Pt 10):1512-22. doi: 10.1099/jmm.0.028654-0. Epub 2011 May 19.

PMID:
21596912
8.

Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.

Paltansing S, Tengeler AC, Kraakman ME, Claas EC, Bernards AT.

Microb Drug Resist. 2013 Dec;19(6):469-76. doi: 10.1089/mdr.2013.0058. Epub 2013 Aug 2.

PMID:
23909485
9.

Fluoroquinolone resistance and molecular characterization of gyrA and parC quinolone resistance-determining regions in Escherichia coli isolated from poultry.

Vanni M, Meucci V, Tognetti R, Cagnardi P, Montesissa C, Piccirillo A, Rossi AM, Di Bello D, Intorre L.

Poult Sci. 2014 Apr;93(4):856-63. doi: 10.3382/ps.2013-03627.

PMID:
24706962
10.

Evaluation of the contribution of gyrA mutation and efflux pumps to fluoroquinolone and multidrug resistance in pathogenic Escherichia coli isolates from dogs and cats.

Shaheen BW, Boothe DM, Oyarzabal OA, Wang C, Johnson CM.

Am J Vet Res. 2011 Jan;72(1):25-32. doi: 10.2460/ajvr.72.1.25.

PMID:
21194332
11.

A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.

Xia LN, Li L, Wu CM, Liu YQ, Tao XQ, Dai L, Qi YH, Lu LM, Shen JZ.

Foodborne Pathog Dis. 2010 Feb;7(2):207-15. doi: 10.1089/fpd.2009.0378.

PMID:
19911944
12.

Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration.

Aly SA, Debavalya N, Suh SJ, Oryazabal OA, Boothe DM.

Can J Microbiol. 2012 Nov;58(11):1288-94. doi: 10.1139/w2012-105. Epub 2012 Nov 5.

PMID:
23145826
13.

Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.

Shigemura K, Tanaka K, Yamamichi F, Shirakawa T, Miyake H, Fujisawa M.

Int J Antimicrob Agents. 2012 Dec;40(6):516-20. doi: 10.1016/j.ijantimicag.2012.07.019. Epub 2012 Oct 13.

PMID:
23068598
14.

Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections.

Cooke CL, Singer RS, Jang SS, Hirsh DC.

J Am Vet Med Assoc. 2002 Jan 15;220(2):190-2.

PMID:
12126128
15.

Phylogenetic association of fluoroquinolone and cephalosporin resistance of D-O1-ST648 Escherichia coli carrying blaCMY-2 from faecal samples of dogs in Japan.

Sato T, Yokota S, Okubo T, Usui M, Fujii N, Tamura Y.

J Med Microbiol. 2014 Feb;63(Pt 2):263-70. doi: 10.1099/jmm.0.054676-0. Epub 2013 Feb 21.

PMID:
23429696
16.

The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.

Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I.

Clin Infect Dis. 2010 Aug 1;51(3):280-5. doi: 10.1086/653931.

17.

AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.

Baucheron S, Tyler S, Boyd D, Mulvey MR, Chaslus-Dancla E, Cloeckaert A.

Antimicrob Agents Chemother. 2004 Oct;48(10):3729-35.

18.

Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.

Gebru E, Damte D, Choi MJ, Lee SJ, Kim YH, Park SC.

Vet Microbiol. 2012 Jan 27;154(3-4):384-94. doi: 10.1016/j.vetmic.2011.07.033. Epub 2011 Aug 6.

PMID:
21893387
19.

Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.

Fàbrega A, Martin RG, Rosner JL, Tavio MM, Vila J.

Antimicrob Agents Chemother. 2010 Mar;54(3):1218-25. doi: 10.1128/AAC.00944-09. Epub 2009 Dec 14.

20.

Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.

Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, Harada Y, Kadowaki M, Shimono N, Kang D.

Int J Antimicrob Agents. 2010 Apr;35(4):387-91. doi: 10.1016/j.ijantimicag.2009.12.005.

PMID:
20138480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk